• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名多发性骨髓瘤患者合并 COVID-19 感染

COVID-19 Coinfection with in a Patient with Multiple Myeloma.

作者信息

Rodriguez Jose A, Bonnano Charles, Khatiwada Pratik, Roa Alejandra A, Mayer Daniel, Eckardt Paula A

机构信息

Department of Internal Medicine, Memorial Healthcare System, Pembroke Pines, FL, USA.

Division of Critical Care Memorial Hospital West, Memorial Healthcare, Pembroke Pines, FL, USA.

出版信息

Case Rep Infect Dis. 2021 Jan 15;2021:8840536. doi: 10.1155/2021/8840536. eCollection 2021.

DOI:10.1155/2021/8840536
PMID:33505740
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7814410/
Abstract

BACKGROUND

Coronavirus disease (COVID-19) is a worldwide pandemic causing multiple fatalities and morbidities worldwide. We report a case of severe pneumonia causing acute respiratory distress syndrome due to a coinfection with SARS-CoV-2 and in an elderly patient with multiple myeloma in Florida, USA. . An 84-year-old male with a medical history significant for multiple myeloma not in remission was sent to the emergency department to rule out COVID-19 infection prior to continuing his chemotherapy sessions. At presentation, he had nonspecific mild symptoms and an unremarkable physical examination. He had significant blood test findings including serum lactate dehydrogenase 373 U/L, high sensitive C-reactive protein 17.40 mg/l, and ferritin 415 ng/ml. Xpert-SARS-CoV-2 was positive. Chest radiograph revealed patchy areas of interstitial infiltrates in mid to lower lung zones. During his hospitalization course, his oxygenation deteriorated, requiring mechanical intubation. Repeat chest radiograph showed worsening bilateral infiltrates. He was started on broad-spectrum antibiotics and eventually weaned off mechanical intubation and extubated. On the 11 day of admission, he was found to be bradycardic and in shock, and he was reintubated. His labs showed worsening inflammatory markers along with kidney dysfunction to the point of requiring renal replacement therapy. He received both convalescent plasma and remdesivir for treatment of COVID-19 pneumonia. Eventually, repeat blood cultures came back positive for the growth of acid-fast beaded bacilli. While awaiting final culture and sensitivity reports, his antibiotics were upgraded to cover possible nocardia infection. Repeat blood and sputum cultures resulted in growth of AFB bacilli 1 week after.

CONCLUSIONS

This case report highlights the importance of keeping a broad differential and considering multiple coinfections, including atypical ones during this COVID-19 pandemic, such as the one that was discussed above, , in order to provide goal-directed therapy.

摘要

背景

冠状病毒病(COVID-19)是一场全球大流行疾病,在全球范围内导致了多起死亡和发病案例。我们报告了美国佛罗里达州一名患有多发性骨髓瘤的老年患者因感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)合并感染而导致严重肺炎并引发急性呼吸窘迫综合征的病例。一名84岁男性,有显著的多发性骨髓瘤病史且病情未缓解,在继续化疗前被送往急诊科以排除COVID-19感染。就诊时,他有非特异性轻度症状,体格检查无异常。他的血液检查结果显著,包括血清乳酸脱氢酶373 U/L、高敏C反应蛋白17.40 mg/l和铁蛋白415 ng/ml。Xpert-SARS-CoV-2检测呈阳性。胸部X线片显示中至下肺区有斑片状间质浸润。在住院期间,他的氧合情况恶化,需要机械通气。复查胸部X线片显示双侧浸润加重。他开始接受广谱抗生素治疗,最终脱机拔管。入院第11天,他出现心动过缓和休克,再次插管。他的实验室检查显示炎症指标恶化,同时出现肾功能障碍,需要进行肾脏替代治疗。他接受了恢复期血浆和瑞德西韦治疗COVID-19肺炎。最终,重复血培养结果显示抗酸串珠杆菌生长呈阳性。在等待最终培养和药敏报告期间,他的抗生素升级以覆盖可能的诺卡菌感染。1周后,重复血液和痰培养结果显示抗酸杆菌生长。

结论

本病例报告强调了在COVID-19大流行期间保持广泛鉴别诊断并考虑多种合并感染(包括非典型感染,如上述讨论的感染)的重要性,以便提供目标导向治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d203/7814410/2f592bf07d43/CRIID2021-8840536.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d203/7814410/fe72963d70af/CRIID2021-8840536.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d203/7814410/2f592bf07d43/CRIID2021-8840536.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d203/7814410/fe72963d70af/CRIID2021-8840536.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d203/7814410/2f592bf07d43/CRIID2021-8840536.002.jpg

相似文献

1
COVID-19 Coinfection with in a Patient with Multiple Myeloma.一名多发性骨髓瘤患者合并 COVID-19 感染
Case Rep Infect Dis. 2021 Jan 15;2021:8840536. doi: 10.1155/2021/8840536. eCollection 2021.
2
Pearls and oy-sters: tuberculous meningitis: not a diagnosis of exclusion.珍珠与牡蛎:结核性脑膜炎:并非排除性诊断。
Neurology. 2013 Jan 22;80(4):e36-9. doi: 10.1212/WNL.0b013e31827f0832.
3
Spontaneous Hemoptysis in a Patient With COVID-19.COVID-19 患者的自发性咯血。
Chest. 2021 Jul;160(1):e39-e44. doi: 10.1016/j.chest.2021.01.069.
4
Severe acute respiratory syndrome coronavirus 2-induced acute aortic occlusion: a case report.严重急性呼吸综合征冠状病毒 2 引起的急性主动脉闭塞:一例报告。
J Med Case Rep. 2021 Mar 2;15(1):112. doi: 10.1186/s13256-021-02692-x.
5
Co-infection of COVID-19 and influenza A in a hemodialysis patient: a case report.COVID-19 与甲型流感病毒在血液透析患者中的合并感染:一例报告。
BMC Infect Dis. 2021 Jan 13;21(1):68. doi: 10.1186/s12879-020-05723-y.
6
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
7
Refractory Acute Respiratory Distress Syndrome Secondary to COVID-19 Successfully Extubated to Average Volume-assured Pressure Support Non-invasive Ventilator.新型冠状病毒肺炎继发难治性急性呼吸窘迫综合征成功撤机至平均容量保证压力支持无创通气模式
Cureus. 2020 Apr 27;12(4):e7849. doi: 10.7759/cureus.7849.
8
Miliary tuberculosis in an immunocompetent male with a fatal outcome.一名免疫功能正常男性的粟粒性肺结核,预后致命。
BMJ Case Rep. 2016 Nov 2;2016:bcr2016216720. doi: 10.1136/bcr-2016-216720.
9
Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.未确诊的强直性脊柱炎病例中的血清阳性视神经脊髓炎:一个神经风湿病学难题
Qatar Med J. 2022 Jul 7;2022(3):29. doi: 10.5339/qmj.2022.29. eCollection 2022.
10
SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.SARS-CoV-2 感染免疫功能低下患者:体液免疫与细胞免疫。
J Immunother Cancer. 2020 Jul;8(2). doi: 10.1136/jitc-2020-000862.

引用本文的文献

1
Disseminated Nontuberculous Mycobacterium Infection During Treatment of Multiple Myeloma: A Case Report and Review of the Literature.多发性骨髓瘤治疗期间播散性非结核分枝杆菌感染:一例报告并文献复习
Intern Med. 2025 Apr 15;64(8):1275-1279. doi: 10.2169/internalmedicine.4234-24. Epub 2024 Sep 4.
2
COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis.COVID-19 恢复期血浆治疗免疫功能低下患者:系统评价和荟萃分析。
JAMA Netw Open. 2023 Jan 3;6(1):e2250647. doi: 10.1001/jamanetworkopen.2022.50647.
3
Molecular identification of nontuberculous mycobacteria using the rpoB, argH and cya genes analysis.

本文引用的文献

1
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.非结核分枝杆菌肺病治疗:美国胸科学会/欧洲呼吸学会/欧洲临床微生物学和传染病学会/美国感染病学会临床实践指南。
Clin Infect Dis. 2020 Aug 14;71(4):905-913. doi: 10.1093/cid/ciaa1125.
2
Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19.新出现的冠状病毒:首例SARS、第二例MERS和第三例SARS-CoV-2:新型冠状病毒肺炎的流行病学新进展
Infez Med. 2020 Jun 1;28(suppl 1):6-17.
3
Coinfection with SARS-CoV-2 and other respiratory pathogens in patients with COVID-19 in Guangzhou, China.
使用rpoB、argH和cya基因分析对非结核分枝杆菌进行分子鉴定。
AMB Express. 2022 Sep 19;12(1):121. doi: 10.1186/s13568-022-01463-1.
4
Clinical Features and Treatment Outcome of Coronavirus and Tuberculosis Co-Infected Patients: A Systematic Review of Case Reports.冠状病毒与结核病合并感染患者的临床特征及治疗结果:病例报告的系统评价
Infect Drug Resist. 2022 Jul 27;15:4037-4046. doi: 10.2147/IDR.S370837. eCollection 2022.
5
Ventilator-associated pneumonia in critically ill patients with COVID-19 infection: a narrative review.新型冠状病毒肺炎(COVID-19)感染重症患者的呼吸机相关性肺炎:一项叙述性综述
ERJ Open Res. 2022 Jul 25;8(3). doi: 10.1183/23120541.00046-2022. eCollection 2022 Jul.
6
Comparative survival of environmental and clinical Mycobacterium abscessus isolates in a variety of diverse host cells.比较不同宿主细胞中环境和临床分枝杆菌脓肿分离株的生存能力。
J Appl Microbiol. 2022 Apr;132(4):3302-3314. doi: 10.1111/jam.15416. Epub 2022 Jan 4.
7
COVID-19 Virus Infection in Three Patients With Hypogammaglobulinemia.3例低丙种球蛋白血症患者的新型冠状病毒肺炎病毒感染
Cureus. 2021 May 26;13(5):e15256. doi: 10.7759/cureus.15256.
8
Use of convalescent plasma in COVID-19 patients with immunosuppression.COVID-19 免疫抑制患者使用恢复期血浆。
Transfusion. 2021 Aug;61(8):2503-2511. doi: 10.1111/trf.16525. Epub 2021 Jun 1.
中国广州新冠肺炎患者中SARS-CoV-2与其他呼吸道病原体的合并感染
J Med Virol. 2020 Nov;92(11):2381-2383. doi: 10.1002/jmv.26073. Epub 2020 Jul 27.
4
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.活动性肺结核、后遗症与 COVID-19 合并感染:49 例首批队列。
Eur Respir J. 2020 Jul 9;56(1). doi: 10.1183/13993003.01398-2020. Print 2020 Jul.
5
Remdesivir for the Treatment of Covid-19 - Final Report.瑞德西韦治疗 COVID-19 的疗效 - 最终报告。
N Engl J Med. 2020 Nov 5;383(19):1813-1826. doi: 10.1056/NEJMoa2007764. Epub 2020 Oct 8.
6
Co-Infection with SARS-COV-2 and Parainfluenza in a young adult patient with pneumonia: Case Report.一名患有肺炎的年轻成年患者同时感染新冠病毒和副流感病毒:病例报告
IDCases. 2020 Apr 20;20:e00762. doi: 10.1016/j.idcr.2020.e00762. eCollection 2020.
7
Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.细菌和真菌合并感染冠状病毒的个体:一项支持 COVID-19 抗菌药物处方的快速综述。
Clin Infect Dis. 2020 Dec 3;71(9):2459-2468. doi: 10.1093/cid/ciaa530.
8
Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in Patients With Coronavirus Disease 2019.新冠肺炎患者恢复期血浆疗法对病毒脱落和生存的影响。
J Infect Dis. 2020 Jun 16;222(1):38-43. doi: 10.1093/infdis/jiaa228.
9
Clinical Characteristics of Covid-19 in New York City.纽约市新冠肺炎的临床特征
N Engl J Med. 2020 Jun 11;382(24):2372-2374. doi: 10.1056/NEJMc2010419. Epub 2020 Apr 17.
10
Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens.SARS-CoV-2 与其他呼吸道病原体的合并感染率。
JAMA. 2020 May 26;323(20):2085-2086. doi: 10.1001/jama.2020.6266.